Orthofix Enterprise Value Over E B I T D A from 2010 to 2024

OFIX Stock  USD 19.53  0.40  2.09%   
Orthofix Medical Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Orthofix Medical Enterprise Value Over EBITDA regression line of annual values had significance of  0.62 and arithmetic mean of (10.05). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(7.45)
Current Value
(7.07)
Quarterly Volatility
100.2459446
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Orthofix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthofix Medical's main balance sheet or income statement drivers, such as Interest Expense of 9.1 M, Total Revenue of 784 M or Gross Profit of 259.2 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.79. Orthofix financial statements analysis is a perfect complement when working with Orthofix Medical Valuation or Volatility modules.
  
Check out the analysis of Orthofix Medical Correlation against competitors.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Latest Orthofix Medical's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Orthofix Medical over the last few years. It is Orthofix Medical's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthofix Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Pretty Stable
   Enterprise Value Over E B I T D A   
       Timeline  

Orthofix Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(10.05)
Coefficient Of Variation(997.41)
Mean Deviation47.98
Median15.37
Standard Deviation100.25
Sample Variance10,049
Range400
R-Value(0.14)
Mean Square Error10,607
R-Squared0.02
Significance0.62
Slope(3.16)
Total Sum of Squares140,689

Orthofix Enterprise Value Over E B I T D A History

2024 -7.07
2023 -7.45
2022 30.23
2021 30.48
2020 23.17
2019 -369.93
2018 21.69

About Orthofix Medical Financial Statements

Orthofix Medical investors use historical fundamental indicators, such as Orthofix Medical's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthofix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(7.45)(7.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.